iBio (IBIO) Non Operating Interest Expenses (2010 - 2026)

iBio (IBIO) has reported Non Operating Interest Expenses for 16 consecutive years, with -$46000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses fell 204.55% year-over-year to -$46000.0 in Q2 2026; TTM through Jun 2026 was $53000.0, a 75.0% decrease from a year earlier, with the FY2026 full-year figure at $53000.0, down 75.0% from the prior year.
• Non Operating Interest Expenses was -$46000.0 for Q2 2026 at iBio, down from $22000.0 in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $225000.0 in Q2 2022 and troughed at -$46000.0 in Q2 2026.
• A 5-year average of $46562.5 and a median of $38500.0 in 2025 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses jumped 252.94% in 2024 and tumbled 204.55% in 2026, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at $31000.0 in 2022, then climbed by 9.68% to $34000.0 in 2023, then surged by 67.65% to $57000.0 in 2024, then declined by 28.07% to $41000.0 in 2025, then tumbled by 212.2% to -$46000.0 in 2026.
• The last three Non Operating Interest Expenses figures came in at -$46000.0 (Q2 2026), $22000.0 (Q1 2026), and $41000.0 (Q4 2025), per Business Quant data.